Search results for plasma
Accelerators and Light Sources of Tomorrow (Part 2: Accelerating with Light)
Dec 22, 2009 |
4.8 / 5 (6) |
0
Accelerators are far from achieving the highest energies their builders aspire to, but size and cost may limit the kinds of facilities funding agencies can support. In the future, new kinds of machines will ...
Physicists see through the opaque with 'T-rays'
Dec 18, 2009 |
4.2 / 5 (11) |
0
"T-rays" may make X-rays obsolete as a means of detecting bombs on terrorists or illegal drugs on traffickers, among other uses, contends a Texas A&M physicist who is helping lay the theoretical groundwork to make the concept ...
A New Method of Estimating Stellar Distances
Dec 21, 2009 |
4.4 / 5 (14) |
2
(PhysOrg.com) -- The star Chi Cygni is located about 550 light-years away, in the direction of the constellation of Cygnus the Swan. It is a notable star because, unlike the sun which still burns hydrogen ...
Understanding relationship of proteins, fatty acids could help treat diseases
Dec 22, 2009 |
not rated yet |
0
(PhysOrg.com) -- It's widely understood that eating a diet high in saturated fats increases the risk for a long list of chronic and deadly diseases, including diabetes and coronary heart disease. Understanding ...
Digital Quantum Battery Could Boost Energy Density Tenfold
Dec 22, 2009 |
4.9 / 5 (28) |
9
(PhysOrg.com) -- Physicists theorize that quantum phenomena could provide a major boost to batteries, with the potential to increase energy density up to 10 times that of lithium ion batteries. According to ...
Polluting pets: the devastating impact of man's best friend
Dec 21, 2009 |
1.7 / 5 (26) |
26
Man's best friend could be one of the environment's worst enemies, according to a new study which says the carbon pawprint of a pet dog is more than double that of a gas-guzzling sports utility vehicle.
Drug for Multiple Myeloma Demonstrated to Significantly Extend Disease-Free Survival
Dec 21, 2009 |
5 / 5 (1) |
0
(PhysOrg.com) -- Initial results from a large, randomized clinical trial for patients with multiple myeloma, a cancer of the blood and bone marrow, showed that patients who received the oral drug lenalidomide (Revlimid, also ...
